Akt (pan) Antibody

Skip to product information
1 of 2

Selleck Chemicals

SKU:F3511-20UL

Regular price €149,00 EUR
Regular price Sale price €149,00 EUR
Sale Sold out
Taxes included. Shipping calculated at checkout.
Size
Quantity
View full details

About the Target

Akt (pan) is a target of interest in many antibody-based workflows. AKT, also known as protein kinase B (PKB), is a family of three serine/threonine kinases: AKT1, AKT2, and AKT3. These kinases are central regulators of cell survival, growth, proliferation, metabolism, and migration. All AKT isoforms share a conserved structure with an N-terminal pleckstrin homology (PH) domain for membrane targeting, a central kinase domain, and a C-terminal regulatory domain. Depending on the literature source, Akt (pan) may also be discussed as Akt (pan) and RAC-alpha serine/threonine-protein kinase; Protein kinase B (PKB); Protein kinase B alpha (PKB alpha); Proto-oncogene c-Akt; RAC-PK-alpha; AKT1; PKB; RAC; RAC-gamma serine/threonine-protein kinase; Protein kinase Akt-3; Protein kinase B gamma (PKB gamma); RAC-PK-gamma; STK-2; AKT3; PKBG; RAC-beta serine/threonine-protein kinase; Protein kinase Akt-.

Reported cellular context includes cell membrane, cytoplasm, endosome, and membrane, which can matter when signal is compared across treatments or changing cell states. Following Akt (pan) across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state. In practice, this target is often considered at the family or isoform-group level, so experimental interpretation benefits from matched controls and clear comparison logic.

Research Context

Akt (pan) is commonly interpreted in the context of cancer, neuroscience, and metabolism research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cell membrane, cytoplasm, and endosome, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

  • apparent redistribution between cell membrane, cytoplasm, and endosome across matched conditions
  • changes associated with proliferative state, oncogenic signaling, or treatment response
  • compartment-specific patterns relevant to neuronal polarity, transport, or synaptic context
  • responses linked to nutrient status, mitochondrial state, or metabolic rewiring

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for Akt (pan). This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in Akt (pan) reflect biology rather than handling. When interpreting Akt (pan), it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep Akt (pan) trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.

Targets:
AKT1 • AKT2 • AKT3
Research Area:
Cancer • Cell Cycle • Cell Signaling • Metabolism • Neuroscience
Application:
FCM • IF • IHC • IP • WB
Reactivity:
Human • Monkey • Mouse • Rat
Specificity:
Akt (pan) Antibody [C11A22] recognizes endogenous levels of total Akt (pan) protein.
Host:
Rabbit
Clonality:
Monoclonal
Clone:
C11A22
UniProt:
P31751Q9Y243P31749
Storage Buffer:
PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN₃
Storage Temperature:
-20°C

For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.

The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.